HIMS · Hims & Hers Health, Inc. · Share Buybacks
One customer — 10% of receivables (December 31, 2025)
“As of December 31, 2025, one customer or partner individually represented more than 10% of accounts receivable.”
4 customers — 10% of receivables (December 31, 2024)
“As of December 31, 2024, four customers or partners individually represented more than 10% of accounts receivable.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-07-01 | $100,000,000 | $55,000,000 | 2025-11-03 | 2027-08-31 | 8-K , filed 2025-11-03 |
Cash spent on buybacks by quarter
Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-09-30 YTD | $0 | 10-Q, filed 2026-11-09 | ||
| 2025-12-31 | $89,960,000 | 10-K, filed 2026-02-23 | ||
| 2024-12-31 | $83,039,000 | 10-K, filed 2026-02-23 | ||
| 2023-12-31 | $1,999,000 | 10-K, filed 2026-02-23 | ||